Joint ASA and WFSA Webinar: Mitochondrial-Linked Hypersensitivity to Volatile Anesthetics: Unraveling a Newly Described and Rare Genetic Disorder

Saturday, 22 August 2026 | 15:00 BST | 14:00 UTC | 10:00 EDT

Join the ASA and WFSA for a free webinar on August 22^nd exploring mitochondrial-linked hypersensitivity to volatile anaesthetics, a newly described and rare genetic disorder with significant implications for patient safety and anaesthetic practice. International experts will examine the scientific foundations, emerging clinical evidence, screening and management strategies, and lessons learned from real-world cases, while highlighting the vital role of global collaboration in addressing this evolving challenge.

After this webinar, participants will be able to:

1. Explain the genetic basis of mitochondrial-linked hypersensitivity to volatile anaesthetics.
2. Describe the screening process and role of genetic testing in identifying at-risk patients.
3. Formulate an anaesthetic plan for patients who screen positive.
4. Describe intraoperative monitoring and perioperative decision-making for these patients.
5. Recognise the ASA and WFSA’s role in fostering international collaboration on emerging patient safety concerns.